Clenergen Corporation was pleased to announce this morning that it has closed the previously announced share exchange agreement with Clenergen Corporation Limited, a United Kingdom Corporation (“Clenergen UK”). As previously agreed upon, the company issued 13,643,045 restricted shares of its common stock to the former shareholders of Clenergen UK.
Clenergen was also pleased to announce that it has appointed Dr. Arvind Pandalai, Mr. Robert Kohn, Mr. David Sonnenberg, Mr. Mike Starkie, Mr Dale Shepherd and Mr. Jack Dickey to its board of directors. Details regarding the closing of the share exchange agreement can be found in the company’s continuous disclosure documents as filed on www.sec.gov.
Let us hear your thoughts: Clenergen Corporation Message Board